Breast density: A biomarker to better understand and prevent breast cancer;La densité mammaire: Un biomarqueur pour mieux comprendre et prévenir le cancer du sein

Bulletin du Cancer

Volumn 93, Issue 9, 2006, Pages 847-855

  Brisson, Jacques ^a,b,c   Bérubé, Sylvie ^a   Diorio, Caroline ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

Author keywords

Breast cancer; Breast density; Calcium; Genetic polymorphisms; Insulin like growth factors; Prevention; Vitamin D

Indexed keywords

BIOLOGICAL MARKER; CALCIUM; GROWTH FACTOR; VITAMIN D; 1,25-DIHYDROXYVITAMIN D; 25 HYDROXYERGOCALCIFEROL; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; CALCITRIOL; CALCITRIOL RECEPTOR; DRUG DERIVATIVE; SOMATOMEDIN; TAMOXIFEN; TUMOR MARKER;

BREAST CANCER; CANADA; CANCER CENTER; CANCER CONTROL; CANCER RISK; CONTROLLED STUDY; DNA POLYMORPHISM; EVALUATION; FEMALE; HEALTH CARE POLICY; HUMAN; MAMMOGRAPHY; MEDICAL PRACTICE; MORTALITY; ONCOLOGY; PREMENOPAUSE; REVIEW; VITAMIN BLOOD LEVEL; VITAMIN INTAKE; BLOOD; BREAST; BREAST TUMOR; CALCIUM INTAKE; DRUG EFFECT; GENETIC POLYMORPHISM; GENETICS; METABOLISM; PATHOLOGY; RISK ASSESSMENT;

25-HYDROXYVITAMIN D 2; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST; BREAST NEOPLASMS; CALCIUM, DIETARY; FEMALE; HUMANS; MAMMOGRAPHY; POLYMORPHISM, GENETIC; PREMENOPAUSE; QUEBEC; RECEPTORS, CALCITRIOL; RISK ASSESSMENT; SOMATOMEDINS; TAMOXIFEN; TUMOR MARKERS, BIOLOGICAL; VITAMIN D;

EID: 33749067457     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Théberge I, Hebert-Croteau N, Langlois A, Major D, Brisson J. Volume of screening mammography and performance in the Quebec population-based Breast Cancer Screening Program. CMAJ 2005; 172: 195-9.
2. Jean S, Major D, Rochette L, Brisson J. Screening mammography participation and invitational strategy: the Quebec Breast Cancer Screening Program, 1998-2000. Chronic Dis Can 2005; 26: 52-8.
3. Perron L, Major D, Hébert-Croteau N, Brisson J. Surveillance de la lutte contre le cancer du sein: évolution, entre 1993 et 1998, de l'étendue de la maladie au diagnostic, des procédures d'investigation, du traitement et de la survie relative. Québec: ISBN PDF: 2-550-45918-0, 2005.
4. Bédard C, Major D, Ladouceur-Kègle P, Guertin M, Brisson J. Soins palliatifs de fin de vie au Québec: définition et mesure d'indicateurs. Québec: ISBN 2-550-46753-1, 2006.
5. Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 2005; 353: 1784-92.
6. Wolfe JN. Risk for breast cancer development determined by mammographic parenchymal pattern. Cancer 1976; 37: 2486-92.
7. Brisson J, Merletti F, Sadowsky NL, Twaddle JA, Morrison AS, Cole P. Mammographic features of the breast and breast cancer risk. Am J Epidemiol 1982; 115: 428-37.
8. Boyd NF, Rommens JM, Vogt K, Lee V, Hopper JL, Yaffe MJ, et al. Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol 2005; 6: 798-808.
9. Brisson J, Diorio C, Mâsse B. Wolfe's parenchymal pattern and percentage of the breast with mammographic densities: redundant or complementary classifications? Cancer Epidemiol Biomarkers Prev 2003; 12: 728-32.
10. Brisson J, Morrison AS, Khalid N. Mammographic parenchymal features and breast cancer detection demonstration project. J Natl Cancer Inst 1988; 80: 1534-40.
11. Byrne C, Schairer C, Wolfe J, Parekh N, Salane M, Brinton LA, et al. Mammographic features and breast cancer risk: Effects with time, age, and menopause status. J Natl Cancer Instit 1995; 87: 1622-9.
12. Brisson J, Morrison AS, Burstein N, Kopans DB, Sadowsky NS, Kalisher L, et al. Mammographic parenchymal patterns and histologic characteristics of breast tissue. Breast Dis 1989; 1: 253-60.
13. Brisson J, Sadowsky NL, Twaddle JA, Morrison AS, Cole P, Merletti F. The relation of mammographic features of the breast to breast cancer risk factors. Am J Epidemiol 1982; 115: 439-43.
14. Meyer F, Brisson J, Morrison AS, Brown JB. Endogenous sex hormones, prolactin, and mammographic features of breast tissue in premenopausal women. J Natl Cancer Instit 1986; 77: 617-20.
15. Brisson J, Verreault R, Morrison AS, Tennina S, Meyer F. Diet, mammographic features of breast tissue, and breast cancer risk. Am J Epidemiol 1989; 130: 14-24.
16. Brisson J. Family history of breast cancer, mammographic features of breast tissue, and breast cancer risk. Epidemiology 1991; 2: 440-4.
17. Pike MC. The role of mammographic density in evaluating changes in breast cancer risk. Gynecol Endocrinol 2005; 21(Suppl 1): 1-5.
18. Schatzkin A, Gail M. The promise and peril of surrogate end points in cancer research. Nat Rev Cancer 2002; 2: 19-27.
19. Cuzick J, Forbes J, Edwards R, Baum M, Cawthorn S, Coates A, et al. First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial. Lancet 2002; 360: 817-24.
20. Brisson J, Brisson B, Côté G, Maunsell E, Bérubé S, Robert J. Tamoxifen and mammographic breast densities. Cancer Epidemiol Biomarkers Prev 2000; 9: 911-5.
21. Cuzick J, Warwick J, Pinney E, Warren RM, Duffy SW. Tamoxifen and breast density in women at increased risk of breast cancer. J Natl Cancer Inst 2004; 96: 621-8.
22. Bérubé S, Diorio C, Verhoek-Oftedahl W, Brisson J. Vitamin D, calcium, and mammographic breast densities. Cancer Epidemiol Biomarkers Prev 2004; 13: 1466-72.
23. Bérubé S, Diorio C, Mâsse B, Hébert-Croteau N, Byrne C, Côté G, et al. Vitamin D and calcium intakes from food or supplements and mammographic breast densities. Cancer Epidemiol Biomarkers Prev 2005; 14: 1653-9.
24. Garland CF, Garland FC, Gorham ED, Lipkin M, Newmark H, Mohr SB, et al. The role of vitamin D in cancer prevention. Am J Public Health 2006; 96: 252-61.
25. Diorio C, Bérubé S, Byrne C, Masse B, Hebert-Croteau N, Yaffe M, et al. Influence of insulin-like growth factors on the strength of the relation of vitamin D and calcium intakes to mammographic breast density. Cancer Res 2006; 66: 588-97.
26. Diorio C, Pollak M, Byrne C, Masse B, Hebert-Croteau N, Yaffe M, et al. Insulin-like growth factor-I, IGF-binding protein-3, and mammographic breast density. Cancer Epidemiol Biomarkers Prev 2005; 14: 1065-73.
27. Holmes MD, Hankinson SE, Byrne C. Mammographic density and diet. Am J Epidemiol 2001; 153: S109.
28. Vachon CM, Kushi LH, Cerhan JR, Kuni CC, Sellers TA. Association of diet and mammographic breast density in the Minnesota breast cancer family cohort. Cancer Epidemiol Biomarkers Prev 2000; 9: 151-60.
29. Colangelo LA, Chiu BCH, Lopez P, Scholtens D, Willis LC, Hendrick RE, et al. A pilot study of vitamin D, calcium, and percent breast density in hispanic women. Nutr Res 2006; 26: 11-5.
30. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 1999; 69: 842-56.
31. Holick MF. Evolution and function of vitamin D. Recent Results Cancer Res 2003; 164: 3-28.
32. Hiatt RA, Krieger N, Lobaugh B, Drezner MK, Vogelman JH, Orentreich N. Prediagnostic serum vitamin D and breast cancer. J Natl Cancer Inst 1998; 90: 461-3.
33. Janowsky EC, Lester GE, Weinberg CR, Millikan RC, Schildkraut JM, Garrett PA, et al. Association between low levels of 1,25-dihydroxyvitamin D and breast cancer risk. Public Health Nutr 1999; 2: 283-91.
34. Lowe LC, Guy M, Mansi JL, Peckitt C, Bliss J, Wilson RG, et al. Plasma 25-hydroxy vitamin D concentrations, vitamin D receptor genotype and breast cancer risk in a UK Caucasian population. Eur J Cancer 2005; 41: 1164-9.
35. Bertone-Johnson ER, Chen WY, Holick MF, Hollis BW, Colditz GA, Willett WC, et al. Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2005; 14: 1991-7.
36. Lim HS, Roychoudhuri R, Peto J, Schwartz G, Baade P, Møller H. Cancer survival is dependent on season of diagnosis and sunlight exposure. Intern J Cancer 2006; 119: 1530-6.
37. Sinotte M, Diorio C, Bérubé S, Ayotte P, Rousseau F, Brisson J. Vitamin D Receptor Polymorphisms BSM1 and FOK1 and Invasive Breast Cancer Risk in postmenopausal women. 2006 (soumis pour publication).
38. Peters U, Chatterjee N, Yeager M, Chanock SJ, Schoen RE, McGlynn KA, et al. Association of genetic variants in the calcium-sensing receptor with risk of colorectal adenoma. Cancer Epidemiol Biomarkers Prev 2004; 13: 2181-6.
39. Pollak MN, Schernhammer ES, Hankinson SE. Insulin-like growth factors and neoplasia. Nat Rev Cancer 2004; 4: 505-18.
40. Kaaks R. Nutrition, insulin, IGF-1 metabolism and cancer risk: a summary of epidemiological evidence. Novartis Found Symp 2004; 262: 247-60; (discussion 260-68).
41. Rinaldi S, Kaaks R, Zeleniuch-Jacquotte A, Arslan AA, Shore RE, Koenig KL, et al. Insulin-like growth factor-I, IGF binding protein-3, and breast cancer in young women: a comparison of risk estimates using different peptide assays. Cancer Epidemiol Biomarkers Prev 2005; 14: 48-52.
42. Diorio C, Pollak M, Byrne C, Masse B, Hebert-Croteau N, Yaffe M, et al. Levels of C-peptide and mammographic breast density. Cancer Epidemiol Biomarkers Prev 2005; 14: 2661-4.
43. Lai JH, Vesprini D, Zhang W, Yaffe MJ, Pollak M, Narod SA. A polymorphic locus in the promoter region of the IGFBP3 gene is related to mammographic breast density. Cancer Epidemiol Biomarkers Prev 2004; 13: 573-82.
44. dos Santos Silva I, Johnson N, De Stavola B, Torres-Mejia G, Fletcher O, Allen DS, et al. The insulin-like growth factor system and mammographic features in premenopausal and postmenopausal women. Cancer Epidemiol Biomarkers Prev 2006; 15: 449-55.
45. Chokkalingam AP, McGlynn KA, Gao YT, Pollak M, Deng J, Sesterhenn IA, et al. Vitamin D receptor gene polymorphisms, insulin-like growth factors, and prostate cancer risk: a population-based case-control study in China. Cancer Res 2001; 61: 4333-6.
46. Bryant RJ, Cadogan J, Weaver CM. The new dietary reference intakes for calcium: implications for osteoporosis. J Am Coll Nutr 1999; 18: 406S-412S.